GreenLight Biosciences (NASDAQ: GRNA)
Some price data may be temporarily unavailable.
GreenLight Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
GreenLight Biosciences Company Info
GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets. The company is headquartered in Medford, MA.
News & Analysis
Featured Article
Why Greenlight Biosciences Stock Was in the Red Today
The company reportedly turned down offers to go private.
Keith Speights | Dec 8, 2022
Featured Article
Why GreenLight Biosciences Stock Is Crushing It Today
The momentum that began earlier this week for the biotech stock is accelerating.
Keith Speights | Aug 4, 2022
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.